Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"excerpt":{"rendered":"
Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"ism_preview":{"drugs":[{"title":"\u0130soptin 80 mg (Turkish record)","url":"https:\/\/www.ortaakarsu.net\/?ism_drug=isoptin-80-mg","facts":[{"label":"Active ingredient \/ generic name","value":"Verapamil Hidroklor\u00fcr"},{"label":"ATC code","value":"C08DA01"}]},{"title":"Ubrogepant","url":"https:\/\/www.ortaakarsu.net\/?ism_drug=ubrogepant","facts":[{"label":"Active ingredient \/ generic name","value":"ubrogepant"}]}],"record":[{"label":"Record type","value":"Published interaction record"},{"label":"Source record version","value":"DailyMed SPL version 28; effective 2025-06-05; retrieved 2026-11-04"}],"sources":[{"label":"UBRELVY (ubrogepant) \u2014 US prescribing information, DailyMed","url":"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=fd9f9458-fd96-4688-be3f-f77b3d1af6ab"},{"label":"FDA: clinical examples of drugs interacting with CYP enzymes and transporter systems","url":"https:\/\/www.fda.gov\/drugs\/drug-interactions-labeling\/healthcare-professionals-fdas-examples-drugs-interact-cyp-enzymes-and-transporter-systems"}],"reviewed_at":"2026-11-04"},"ism_access":{"required":true,"resource_key":"pair:35799","available":true}}